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The Question
High frequency stimulation of the subthalamic nucleus (STN) is an effective treatment for patients
with Parkinson’s disease (PD) (Odekerken et al., 2012; Kocabicak et al., 2013; Schuepbach et al.,
2013). The technique has been further refined throughout the years by improved magnetic
resonance imaging (MRI) techniques, advanced neurophysiological recording possibilities, and
advances in hardware and software technology (Kocabicak and Temel, 2013). There are at least
two major determining factors for an acceptable therapeutic outcome: patient selection (Deuschl
et al., 2006) and the accuracy of targeting of the relatively small STN (Temel et al., 2005). The
latter requires a state-of-the art stereotactic approach, adequate imaging facilities, and a detailed
neurophysiological mapping of the target area. The preferred area within the STN is the motor
part (thought to be located dorsolaterally in the STN), which can, be to some extent, identified
by intraoperative multi-unit activity analyses, and MRI-based tractography (Zaidel et al., 2010;
Brunenberg et al., 2011).
While the STN could not be visualized on MRI images when modern DBS of the STN surgeries
started in Grenoble in 1993, nowadays its visualization has become a routine procedure for most
centers offering DBS for patients with PD. While using intraoperative electrophysiology was
evident in the beginning, now it is questioned whether it still has an essential added value. In this
opinion article, we aim to provide an answer on the question whether or not electrophysiology still
has a clinically relevant role in this era of advanced neuroimaging technology, which enables us to
visualize both function and structure anatomy.
Old Debate
The discussion of whether or not to use intraoperative microelectrode recording (MER) is not
a new one (Hariz, 2002). This discussion was perhaps less vivid when modern DBS started to
be applied in patients with PD. The STN was an invisible target on MR images in most centers
and MER was considered very helpful to find and delineate the boundaries of the target (Pollak
et al., 1993; Limousin et al., 1995; Shamir et al., 2012). Since then things have changed. However,
currently the STN can be directly visualized on T2 weighed and susceptibility weighed MR images.
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The imaging field progresses rapidly further with ultra-high
field imaging modalities becoming now available for patients
(Plantinga et al., 2014).
It is more than 15 years ago that that the visualization of
the STN for DBS surgeries was described (Starr et al., 1999).
Mostly, T2 weighed and inversion recovery MRI sequences have
been used. In most of the patients, the predefined target on T2
weighed MR images was chosen for implantation after intra-
operative electrophysiology and test-stimulation (Bejjani et al.,
2000; Egidi et al., 2002; Starr et al., 2002). This meant that in most
patientsMRI images could reliably show the STN, except for the y
axis, in which microelectrode recording (MER) indicated that the
STN extended more anteriorly than suggested by MRI (Hamani
et al., 2005). Detailed volumetric analysis of MER-determined
borders of the STN and MRI- defined borders in 22 patients (44
STN’s), showed that MER-determined borders of the STN were
exceeding the MRI signal (Schlaier et al., 2011). In addition, we
examined the entry and exit borders of the STN on MRI images
and with MER, using the probe’s eye trajectory (Kocabicak et al.,
2013). We found that T2 weighed MRI could reliably predict the
electrophysiological entry and exit of the STN. Although these
data confirm the accuracy of MRI in visualizing the STN, there
are also limitations. There are known variations between the
patients with respect to the x, y, and z planes, and the borders
can sometimes be less clear, mainly toward the substantia nigra
pars reticulata (SNr) (Hamani et al., 2005; Kocabicak et al., 2013).
From Atlas-based to MRI Based
Coordinates and from Single-electrode to
Multiple-electrode Recordings
In our previous series of 55 patients with PD who underwent
DBS of the STN, atlas- based coordinates were used and in about
one third of the patients the predefined target (central trajectory)
was used for final electrode implantation, after MER and intra-
operative test-stimulation (Temel et al., 2007). With applying
individually adjusted coordinates based on T2 weighed MRI, the
central trajectory was chosen in about two-thirds of the patients
(Kocabicak et al., 2013; Tonge et al., in press). This has resulted
in a clear reduction in operation time. Similar rates have been
reported by others with atlas-based (Amirnovin et al., 2006) and
MRI-based targeting coordinates (Reck et al., 2012). The change
from 1.5 to 3.0 T has also improved the accuracy of targeting
(Toda et al., 2009; Kerl et al., 2012).
Another development has been the change of single-electrode
to multiple-electrode intra-operative electrophysiological
recordings (Temel et al., 2007). The latter provides more
detailed information about the electrophysiological boundaries
of the STN; however, implantation of several electrodes at one
time might increase the risk of bleeding. We found that the
simultaneous implantation of multiple electrodes did not cause
more bleedings or other major intracranial complication. The
use of multiple electrodes resulted in better motor results when
compared with patients who underwent DBS of the STN guided
with a single recording electrode. There are reports, however,
suggesting increased risk of hemorrhage due to MER (Ben-Haim
et al., 2009; Xiaowu et al., 2010).
Back to the Question
Is intra-operative electrophysiology necessary to find the STN?
Our answer is no based on the advances in MRI technology.
In line with this experienced DBS centers have shown good
outcome with a MRI-guided approach (Ostrem et al., 2013;
Aviles-Olmos et al., 2014). So should we abandon MER then?
In our centers, we have decided not to abandon it for a number
of reasons. Even in experienced centers, in about two-thirds of
the cases, the predefined target is chosen for final implantation.
In one-third, an alternative trajectory is needed. With MER,
alternative trajectories are immediately available. The trajectory
with the second longest and, if needed, the third longest STN
activity can be used as alternative trajectories. Two other less
common reasons to use intra-operative electrophysiology can be
an unexpected error in the stereotactic approach or a shift caused
by excessive CSF leakage or a hematoma (Reck et al., 2012).
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